$IRTC

Rosenbaum Marc Wade sold $79K of IRTC

Rosenbaum Marc Wade (Chief Accounting Officer) sold 729 shares of iRhythm Holdings, Inc. (IRTC) at $108.19 on 2026-06-02.

Original reporting
SEC EDGAR · Rosenbaum Marc Wade
Published Jun 3, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IRTC
Neutral
medium confidence
Mentioned
$IRTC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IRTCNeutralLow
01

Why it matters

The disclosure updates the insider-trading record but does not introduce new operational or financial information about IRTC.

02

Market read

Traders may monitor for clustering of insider sales, but this single transaction alone is unlikely to drive a major repricing.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without context (e.g., options exercises, compensation timing), directional inference is weak.

Relevance 6/10Novelty 6/10Timing: Filed after-hours on 2026-06-03; reflects sale dated 2026-06-02.

Background

The filing is an SEC Form 4 insider transaction disclosure for iRhythm Holdings, Inc. (IRTC).

Company-level read

Ticker impact

$IRTCNeutralMedium confidence
Context

SEC Form 4 shows Chief Accounting Officer Marc Wade sold 729 shares of iRhythm Holdings on 2026-06-02 at ~$108.19.

Expected impact

Likely limited near-term price impact; treat as low-signal unless repeated or paired with other negative disclosures.

Evidence & confidence

The article provides only an insider transaction datapoint (no 10b5-1 plan, no earnings/guidance/litigation update), which typically has modest standalone market impact.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide trigger.

None indicated.

None indicated.

Counterpoint

Because the sale was not under a 10b5-1 plan, some traders may read it as a stronger signal than routine planned selling—watch for follow-on sales or other insider actions.

Key entities

  • iRhythm Holdings, Inc.

    Subject of the SEC Form 4 insider transaction; officer sold shares on 2026-06-02.

  • Marc Wade Rosenbaum

    Chief Accounting Officer who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IRTCMedAI 9/10

iRhythm (IRTC) Q2 2026 Earnings Call Transcript

iRhythm (IRTC) reported Q2 2026 revenue of $224.2M, up 20.1% YoY, with gross margin at 72.8%. GAAP net loss was $0.4M, and adjusted EBITDA was $43.3M. Full-year revenue guidance is $880M to $890M and adjusted EBITDA margin 13% to 14%. The company agreed to acquire VitalConnect for about $287.5M and received a $50M Baxter settlement.